23 results
8-K
EX-10.2
COGT
Cogent Biosciences Inc
26 Oct 20
Cogent Biosciences Appoints
7:13am
to disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure
424B5
COGT
Cogent Biosciences Inc
20 Mar 20
Prospectus supplement for primary offering
8:26am
the company that issued the stock. If any of our stockholders brought a lawsuit against us, we could incur substantial costs defending the lawsuit … . Such a lawsuit could also divert the time and attention of our management.
On December 31, 2019, we received a letter from the Listing Qualifications Department
8-K
EX-10.1
COGT
Cogent Biosciences Inc
10 Aug 20
Entry into a Material Definitive Agreement
4:31pm
will have no obligation to pay the fees of the Rights Agent or reimburse the Rights Agent for the fees of counsel in connection with any lawsuit
424B5
1l4cqhn 1c54b11
30 Nov 20
Prospectus supplement for primary offering
5:28pm
424B5
qwzzi4o9t 1m4i
2 Dec 20
Prospectus supplement for primary offering
5:06pm
10-Q
ybyldmowcsa6
14 May 18
Quarterly report
7:01am
8-K
EX-2.1
kwiptu7 py
6 Jul 20
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
10:31am
DEFM14A
8eadpwi0kp plqw
9 Oct 20
Proxy related to merger
4:44pm